These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2833301)

  • 1. Hyperthyroxinaemia in hepatocellular carcinoma: relation to thyroid binding globulin in the clinical and preclinical stages of the disease.
    Alexopoulos A; Hutchinson W; Bari A; Keating JJ; Johnson PJ; Williams R
    Br J Cancer; 1988 Mar; 57(3):313-6. PubMed ID: 2833301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroxine binding globulin and thyroid function tests in patients with hepatocellular carcinoma.
    Kalk WJ; Kew MC; Danilewitz MD; Jacks F; van der Walt LA; Levin J
    Hepatology; 1982; 2(1):72-6. PubMed ID: 6274780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis.
    Sorvillo F; Mazziotti G; Carbone A; Morisco F; Cioffi M; Rotondi M; Stornaiuolo G; Amato G; Gaeta GB; Caporaso N; Carella C
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):207-12. PubMed ID: 12580937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thyroxine-binding globulin--not a tumor marker of hepatocellular cancer].
    Sieg A; Schönpflug A; Seitz HK; Kommerell B
    Z Gastroenterol; 1991 Mar; 29(3):101-4. PubMed ID: 1647573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay for serum thyroxine-binding globulin: results in normal subjects and in patients with hepatocellular carcinoma.
    Gershengorn MC; Larsen PR; Robbins J
    J Clin Endocrinol Metab; 1976 May; 42(5):907-11. PubMed ID: 57964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential hormone-binding characteristics of thyroxine-binding globulin in hepatocellular carcinoma and cirrhosis.
    Hutchinson WL; Johnson PJ; White YS; Williams R
    J Hepatol; 1989 Sep; 9(2):265-71. PubMed ID: 2553799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroxine-binding globulin and thyroid hormones after resection of hepatocellular carcinoma.
    Nagasue N; Ohmori H; Hashimoto N; Tachibana M; Kubota H; Uchida M; Yu L
    Am J Gastroenterol; 1997 Jul; 92(7):1187-9. PubMed ID: 9219796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma.
    Huang MJ; Liaw YF
    Am J Gastroenterol; 1990 Mar; 85(3):281-4. PubMed ID: 1689951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Audit of hyperthyroxinaemia and thyrotoxicosis using a sensitive TSH assay.
    O'Hare J; Abuaisha B; Barrett E
    Ir Med J; 1991 Jun; 84(2):70-2. PubMed ID: 1910022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of thyroxine-binding globulin (TBG) as a marker of liver tumors.
    Terui S
    Eur J Nucl Med; 1984; 9(3):121-4. PubMed ID: 6201364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum TBG value in chronic liver diseases and hepatoma with special referrence to microheterogeneity of TBG (author's transl)].
    Miyazaki J; Tanaka N; Iino S; Endo Y
    Horumon To Rinsho; 1982 Feb; 30(2):145-7. PubMed ID: 6177454
    [No Abstract]   [Full Text] [Related]  

  • 12. Normal cellular uptake of thyroxine from serum of patients with familial dysalbuminemic hyperthyroxinemia or elevated thyroxine-binding globulin.
    Sarne DH; Refetoff S
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1166-70. PubMed ID: 3142912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum testosterone: a special feature of hepatocellular carcinoma.
    Lampropoulou-Karatzas C; Goritsas P; Makri MG
    Eur J Med; 1993 Jan; 2(1):23-7. PubMed ID: 8258001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroxine-binding globulin, hyperthyroxinemia and hepatocellular carcinoma.
    Kew MC
    Hepatology; 1991 Apr; 13(4):808-9. PubMed ID: 1849117
    [No Abstract]   [Full Text] [Related]  

  • 15. High serum thyroxine-binding globulin--an important cause of hyperthyroxinaemia.
    Leahy BC; Davies D; Laing I; Walton L
    Postgrad Med J; 1984 May; 60(703):324-7. PubMed ID: 6429654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroxine-binding globulin as a marker of liver tumors.
    Terui S; Moriya Y; Yamamoto H; Koyama Y
    Cancer Detect Prev; 1987; 10(5-6):371-8. PubMed ID: 2436781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism.
    Borzio M; Caldara R; Borzio F; Piepoli V; Rampini P; Ferrari C
    Gut; 1983 Jul; 24(7):631-6. PubMed ID: 6407905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of a thyroxine binding globulin assay in calculating a free thyroxine index in normal, thyroid disease, and sick euthyroid patients.
    Szpunar WE; Stoffer SS; DiGiulio W
    J Nucl Med; 1987 Aug; 28(8):1341-3. PubMed ID: 3112331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthyroxinemia and elevated lipids as paraneoplastic phenomena in hepatocellular carcinoma. A case report.
    Nizam R; Ahmed F
    J Clin Gastroenterol; 1995 Oct; 21(3):246-8. PubMed ID: 8648063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of estrogens and testosterone in cirrhotic men with and without hepatocellular carcinoma.
    Nagasue N; Ogawa Y; Yukaya H; Ohta N; Ito A
    Gastroenterology; 1985 Mar; 88(3):768-72. PubMed ID: 2981753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.